Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The clinical relevance of drug-drug interaction between co-trimoxazole and sacubitril/valsartan treatment in a heart failure patient: a case report and overview of mechanisms and management in clinical practice.

× No keyword cloud information.

8 in total

Review 1. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system.

Authors: Biff F Palmer
Journal: N Engl J Med Date: 2004-08-05 Impact factor: 91.245

2. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

Authors: Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Monica M Colvin; Mark H Drazner; Gerasimos Filippatos; Gregg C Fonarow; Michael M Givertz; Steven M Hollenberg; JoAnn Lindenfeld; Frederick A Masoudi; Patrick E McBride; Pamela N Peterson; Lynne Warner Stevenson; Cheryl Westlake
Journal: J Am Coll Cardiol Date: 2016-05-20 Impact factor: 24.094

Review 3. Drug-induced hyperkalemia.

Authors: Chaker Ben Salem; Atef Badreddine; Neila Fathallah; Raoudha Slim; Houssem Hmouda
Journal: Drug Saf Date: 2014-09 Impact factor: 5.606

4. Association of mineralocorticoid receptor antagonist use and in-hospital outcomes in patients with acute heart failure.

Authors: Vasiliki Bistola; Panagiotis Simitsis; Dimitrios Farmakis; Ignatios Ikonomidis; Georgios Bakosis; Filippos Triposkiadis; Erifili Hatziagelaki; John Lekakis; Alexandre Mebazaa; John Parissis
Journal: Clin Res Cardiol Date: 2017-09-18 Impact factor: 5.460

5. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.

Authors: Hanna Fröhlich; Lorella Torres; Tobias Täger; Dieter Schellberg; Anna Corletto; Syed Kazmi; Kevin Goode; Morten Grundtvig; Torstein Hole; Hugo A Katus; John G F Cleland; Dan Atar; Andrew L Clark; Stefan Agewall; Lutz Frankenstein
Journal: Clin Res Cardiol Date: 2017-04-22 Impact factor: 5.460

6. Angiotensin-neprilysin inhibition versus enalapril in heart failure.

Authors: John J V McMurray; Milton Packer; Akshay S Desai; Jianjian Gong; Martin P Lefkowitz; Adel R Rizkala; Jean L Rouleau; Victor C Shi; Scott D Solomon; Karl Swedberg; Michael R Zile
Journal: N Engl J Med Date: 2014-08-30 Impact factor: 91.245

7. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors: Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal: Eur Heart J Date: 2016-05-20 Impact factor: 29.983

8. Adherence to optimal heart rate control in heart failure with reduced ejection fraction: insight from a survey of heart rate in heart failure in Sweden (HR-HF study).

Authors: M Fu; U Ahrenmark; S Berglund; C J Lindholm; A Lehto; A Månsson Broberg; G Tasevska-Dinevska; G Wikstrom; A Ågard; B Andersson
Journal: Clin Res Cardiol Date: 2017-08-09 Impact factor: 5.460

8 in total